[1] Que w, Rowlands JA. X-ray imaging using amorphous selenium:inherent spatial resolution. Med Phys, 1995,22(4):365-374.
[2] Bristow RE, del Carmen MG, Pannu HK, et al. Clinically occult recurrent ovarian cancer, patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol, 2003, 90(3):519-528.
[3] Lerman H, Metser U, Grisaru D, et al. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients:assessment by PET/CT. J Nucl Med. 2004, 45(2):266-271.
[4] Ryu SY, Kim MH, Choi SC, et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med, 2003,44(3):347-352.
[5] Havnlesky LJ, Wong TZ, Secord AA, et al. The role of PET scanning in the detection of recurrent cervical cancer.Gynecol Oncol, 2003,90(1):186-190.
[6] Umesaki N, Tanaka T, Miyama M, et al. Early diagnosis and evaluation of therapy in postoperative recurrent cervical cancers by positron emission tomography. Oncol Rep, 2000, 7(1):53-56.
[7] Keys HM, Bundy BN, Stehman FB, et al.Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma.a randomized trial of the gynecologic oncology. Gynecol Oncol, 2003, 89(3):343-353.